Velo3D Analyst Price Targets

Wall Street analyst price targets and consensus rating for Velo3D (VELO).

Price Target Range — 3 Quarters

Analyst Consensus — 3 Analysts

3Buy

Consensus RatingOverweight# Analysts3Avg. Consensus PT$22Upside to Avg. PT+148.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 12, 2026	Needham	Austin Bohlig	Maintained	Buy	$33
Aug 12, 2026	Cantor Fitzgerald	Troy Jensen	Maintained	Overweight	$17
Jul 9, 2026	Cantor Fitzgerald	Ryan Tunis	Initiate	Overweight	$17
Jun 25, 2026	Needham	Austin Bohlig	Initiate	Buy	$33
May 13, 2026	Lake Street	Jaeson Schmidt	PT Raise	Buy	$18→$20
Dec 29, 2025	Lake Street	Jaeson Schmidt	PT Raise	Buy	$6→$18
Oct 1, 2025	Lake Street	Jaeson Schmidt	Initiate	Buy	$6

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Needham Reiterates Buy on Velo3D, Maintains $33 Price Target

Needham analyst Austin Bohlig reiterates Velo3D (NASDAQ:VELO) with a Buy and maintains $33 price target.

Benzinga Newsdesk

PRO
Cantor Fitzgerald Reiterates Overweight on Velo3D, Maintains $17 Price Target

Cantor Fitzgerald analyst Troy Jensen reiterates Velo3D (NASDAQ:VELO) with a Overweight and maintains $17 price target.

Benzinga Newsdesk

PRO
Cantor Fitzgerald Initiates Coverage On Velo3D with Overweight Rating, Announces Price Target of $17

Cantor Fitzgerald analyst Ryan Tunis initiates coverage on Velo3D (NASDAQ:VELO) with a Overweight rating and announces Price Target of $17.

Benzinga Newsdesk

PRO
Needham Initiates Coverage On Velo3D with Buy Rating, Announces Price Target of $33

Needham analyst Austin Bohlig initiates coverage on Velo3D (NASDAQ:VELO) with a Buy rating and announces Price Target of $33.

Benzinga Newsdesk

PRO
Lake Street Maintains Buy on Velo3D, Raises Price Target to $20

Lake Street analyst Jaeson Schmidt maintains Velo3D (NASDAQ:VELO) with a Buy and raises the price target from $18 to $20.

Benzinga Newsdesk

Praxis Precision Medicines To Rally More Than 213%? Here Are 8 Top Analyst Forecasts For Monday

Avi Kapoor

Velo3D Inc

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

Velo3D Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Needham Reiterates Buy on Velo3D, Maintains $33 Price Target

PRO
Cantor Fitzgerald Reiterates Overweight on Velo3D, Maintains $17 Price Target

PRO
Cantor Fitzgerald Initiates Coverage On Velo3D with Overweight Rating, Announces Price Target of $17

PRO
Needham Initiates Coverage On Velo3D with Buy Rating, Announces Price Target of $33

PRO
Lake Street Maintains Buy on Velo3D, Raises Price Target to $20

Praxis Precision Medicines To Rally More Than 213%? Here Are 8 Top Analyst Forecasts For Monday

People Also Watch

People Also Watch

Velo3D Inc

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

Velo3D Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRONeedham Reiterates Buy on Velo3D, Maintains $33 Price Target

PROCantor Fitzgerald Reiterates Overweight on Velo3D, Maintains $17 Price Target

PROCantor Fitzgerald Initiates Coverage On Velo3D with Overweight Rating, Announces Price Target of $17

PRONeedham Initiates Coverage On Velo3D with Buy Rating, Announces Price Target of $33

PROLake Street Maintains Buy on Velo3D, Raises Price Target to $20

Praxis Precision Medicines To Rally More Than 213%? Here Are 8 Top Analyst Forecasts For Monday

People Also Watch

People Also Watch

PRO
Needham Reiterates Buy on Velo3D, Maintains $33 Price Target

PRO
Cantor Fitzgerald Reiterates Overweight on Velo3D, Maintains $17 Price Target

PRO
Cantor Fitzgerald Initiates Coverage On Velo3D with Overweight Rating, Announces Price Target of $17

PRO
Needham Initiates Coverage On Velo3D with Buy Rating, Announces Price Target of $33

PRO
Lake Street Maintains Buy on Velo3D, Raises Price Target to $20